KDM5C and endometrial carcinoma: In this pan-cancer analysis, the frequency of KDM5C alterations was 2.1% in a cohort of 45614 cancer patients, with esophagogastric cancer, endometrial carcinoma and renal cell carcinoma having the highest levels of KDM5C alterations, which was similar to previous publications (21, 22).